Expression of bcl-2 protein in chronic hepatitis C: Effect of interferon alpha 2b with ribavirin therapy

doi:10.3748/wjg.v11.i19.2949

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2554)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

290

HTML

2083

Tables (1-3)

181

Sum=2554

May 21, 2005 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. May 21, 2005; 11(19): 2949-2952
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2949

Table 3 Intensity of bcl-2 protein expression on hepatocytes and liver lymphocytes in patients with chronic hepatitis C during IFNα2b and RBV therapy.

Intensity of accumulation	Bcl-2 in hepatocytes (%)		Bcl-2 in liver lymphocytes (%)
Intensity of accumulation	Before	After	Before	After
High granular (n)	21	9	15	13
Moderate (n)	9	21	15	17
χ² test	P>0.1		P>0.5

Citation: Anatol P, Danuta P, Janusz D, Bozena P. Expression of bcl-2 protein in chronic hepatitis C: Effect of interferon alpha 2b with ribavirin therapy. World J Gastroenterol 2005; 11(19): 2949-2952
URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2949.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i19.2949